These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
534 related items for PubMed ID: 26318190
1. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection. Cheah SE, Wang J, Nguyen VT, Turnidge JD, Li J, Nation RL. J Antimicrob Chemother; 2015 Dec; 70(12):3291-7. PubMed ID: 26318190 [Abstract] [Full Text] [Related]
2. fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models. Dudhani RV, Turnidge JD, Nation RL, Li J. J Antimicrob Chemother; 2010 Sep; 65(9):1984-90. PubMed ID: 20573659 [Abstract] [Full Text] [Related]
3. Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models. Dudhani RV, Turnidge JD, Coulthard K, Milne RW, Rayner CR, Li J, Nation RL. Antimicrob Agents Chemother; 2010 Mar; 54(3):1117-24. PubMed ID: 20028824 [Abstract] [Full Text] [Related]
4. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model. Lin YW, Zhou QT, Cheah SE, Zhao J, Chen K, Wang J, Chan HK, Li J. Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207 [Abstract] [Full Text] [Related]
7. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Koomanachai P, Tiengrim S, Kiratisin P, Thamlikitkul V. Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803 [Abstract] [Full Text] [Related]
8. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO. Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [Abstract] [Full Text] [Related]
11. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. Aoki N, Tateda K, Kikuchi Y, Kimura S, Miyazaki C, Ishii Y, Tanabe Y, Gejyo F, Yamaguchi K. J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523 [Abstract] [Full Text] [Related]
16. Treatment of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii pneumonia. Falagas ME, Kasiakou SK, Michalopoulos A. J Cyst Fibros; 2005 May; 4(2):149-50. PubMed ID: 15886070 [No Abstract] [Full Text] [Related]
17. A pharmacokinetic-pharmacodynamic (PKPD) model based on in vitro time-kill data predicts the in vivo PK/PD index of colistin. Khan DD, Friberg LE, Nielsen EI. J Antimicrob Chemother; 2016 Jul; 71(7):1881-4. PubMed ID: 26983860 [Abstract] [Full Text] [Related]
18. Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model. Lin YW, Zhou QT, Han ML, Chen K, Onufrak NJ, Wang J, Turnidge JD, Howden BP, Forrest A, Chan HK, Li J. Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229637 [Abstract] [Full Text] [Related]
19. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model. Song JY, Cheong HJ, Lee J, Sung AK, Kim WJ. Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761 [Abstract] [Full Text] [Related]